Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Colon and Lung Cancer Research Panel vs. Cancer Hotspot Panel

    Hi,

    I plan to detect mutations from DNA derived from lung cancer FFPE sample with Ion PGM Ampliseq. I usually use Cancer Hotspot Panel v2. It works well, but sometimes I don't get a good result or not enough amount of reads to be analyzed.

    I heard about this Colon and Lung Cancer Panel v2, and am thinking about using it. I know the difference is this one has less target gene (22 genes) compare to Cancer Hotspot Panel (50 genes). But besides that, is there any other difference? Can I use the same protocol? The price difference is quite big.

    Please help, I'd really appreciate it.

    Regards.
    Last edited by hanco; 02-16-2017, 05:37 PM.

  • #2
    Hi,
    I worked on the Colon and Lung Cancer Panel v2 for 1 years , i cant tell you that if DNA is good we can sequence around 300 000 reads per sample (we multiplex 16 samples per run). In still good condition we have more than 500X depth coverage per target which is our limit for somatic result. I will ask in my lab if the used Cancer Hotspot Panel before.

    Hope it help a bit.

    Best regards

    Tristan

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Current Approaches to Protein Sequencing
      by seqadmin


      Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
      04-04-2024, 04:25 PM
    • seqadmin
      Strategies for Sequencing Challenging Samples
      by seqadmin


      Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
      03-22-2024, 06:39 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 04-11-2024, 12:08 PM
    0 responses
    18 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 10:19 PM
    0 responses
    22 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-10-2024, 09:21 AM
    0 responses
    17 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 04-04-2024, 09:00 AM
    0 responses
    49 views
    0 likes
    Last Post seqadmin  
    Working...
    X